Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors

American Journal of Pathology

Volumn 149, Issue 6, 1996, Pages 1941-1952

  Brambilla, Elisabeth ^a,b,c   Negoescu, Adrien ^a   Gazzeri, Sylvie ^a   Lantuejoul, Sylvie ^b   Moro, Denis ^a   Brambilla, Christian ^a   Coll, Jean Luc ^a  

^a INSTITUT ALBERT BONNIOT   (France)

^b Laboratoire de Pathologie Cellulaire   (France)

^c GRENOBLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2; PROTEIN P53;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOID; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LARGE CELL CARCINOMA; LUNG CARCINOMA; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; NEUROENDOCRINE TUMOR; PRIORITY JOURNAL;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CARCINOID TUMOR; CARCINOMA, LARGE CELL; CARCINOMA, SMALL CELL; DNA DAMAGE; HUMANS; IMMUNOHISTOCHEMISTRY; LUNG NEOPLASMS; NEUROENDOCRINE TUMORS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029826614     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Arrigoni MG, Woolner LB, Bernatz PE: Atypical carcinoid tumors of the lung. J Thorac Cardiovasc Surg 1972, 64:413-421
2. Travis WD, Linnoila RI, Tsokos MG, Hitchcock CL, Cutler GB, Nieman L, Chrousos G, Pass H, Doppman J: Neuroendocrine tumors of the lung with proposed criteria for large-cell neuroendocrine carcinoma. Am J Surg Pathol 1991, 15:529-553
3. Kerr JFR, Wyllie AH, Currie AH: Apoptosis: a base biological phenomenon with wide ranging implications in tissue kinetics. Br J Cancer 1972, 26:239-257
4. Raff MC: Social controls on cell survival and cell death. Nature 1992, 356:397-400
5. Minna JD: The molecular biology of lung cancer pathogenesis. Chest 1993, 103:4495-4565
6. Johnson BE, Makuch RW, Simmons AD, Gazdar AF, Burch D, Cashell AW: myc family DNA amplification in small cell lung cancer patients' tumors and corresponding cell lines. Cancer Res 1988, 48:5163-5166
7. Takahashi T, Obata Y, Sekido Y, Hida T, Watanabe RUH, Ariyoshi Y, Sugimura T, Takahashi T: Expression and amplification of myc gene family in small cell lung cancer and its relation to biological characteristics. Cancer Res 1989, 49:2683-2688
8. Gazzeri S, Brambilla E, Chauvin C, Jacrot M, Benabid AL, Brambilla C: Analysis of the activation of the myc family oncogene and of its stability over time in xenografted human lung carcinomas. Cancer Res 1990, 50:1566-1570
9. Gazzeri S, Brambilla E, Jacrot M, Chauvin C, Benabid AL, Brambilla C: Activation of myc gene family in human lung carcinomas and during heterotransplantation into nude mice. Cancer Res 1991, 51:2566-2571
10. Harbour JW, Lai SL, Whang-Peng J, Gazdar AF, Minna JD, Kaye FJ: Abnormalities in structure and expression of the human retinoblastoma gene in SCLC. Science 1988, 353:353-357
11. Gouyer V, Gazzeri S, Brambilla E, Bolon I, Moro D, Perron P, Benabid AL, Brambilla C: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer 1994, 58:818-824
12. Brambilla E, Gazzeri S, Moro D, Caron de Fromentel C, Gouyer V, Jacrot M, Brambilla C: Immunohistochemical study of p53 in human lung carcinomas. Am J Pathol 1993, 143:199-210
13. Gazzeri S, Brambilla E, Caron de Fromentel C, Gouyer V, Moro D, Perron P, Berger F, Brambilla C:p53 genetic abnormalities and myc activation in human lung carcinoma, Int J Cancer 1994, 58:24-32
14. Takahashi T, Suzuki H, Hida T, Sekido Y, Ariyoshi Y, Veda R: The p53 gene is very frequently mutated in small-cell lung cancer with a distinct nucleotide substitution pattern. Oncogene 1991, 6:1775-1778
15. Sameshima Y, Matsuno Y, Hirohashi S, Shimosato Y, Mizoguchi H, Sugimura T, Terada M, Yokota J: Alterations of the p53 gene are common and critical events for the maintenance of malignant phenotypes in small-cell lung carcinoma. Oncogene 1992, 7:451-457
16. D'Amico D, Carbone D, Mitsudomi T, Nau M, Fedorko J, Russel E, Johnson B, Buchhagen D, Bodner S, Phelps R, Gazdar A, Minna JD: High frequency of somatically acquired p53 mutations in small-cell lung cancer cell lines and tumors. Oncogens 1992, 7:339-346
17. 2 gene is rearranged in many diffuse B-cell lymphomas. Blood 1988, 71:969-972
18. 2 in hormone-refractory human prostate cancers. Am J Pathol 1993, 143:390-400
19. 2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 1994, 172:337-342
20. 2 protein: a prognostic indicator strongly related to p53 protein in lymph node-negative breast cancer patients. J Natl Cancer Inst 1994, 86:499-504
21. 2 in neuroblastoma is associated with unfavorable histology and N-myc amplification. Am J Pathol 1993, 143:1543-1550
22. 2 protein in non-small-cell lung carcinoma. N Engl J Med 1993, 329:690-694
23. 2 protein: a prognostic factor inversely correlated to p53 in non-small-cell lung cancer, Br J Cancer 1995, 71:1003-1007
24. 2 gene. Cancer Res 1994, 54:3131-3135
25. 2 and bax gene expression in vitro and in vivo. Oncogene 1994, 9:1799-1805
26. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995, 80:293-299
27. 2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993, 74:609-619
28. Negoescu A, Lorimier P, Labat-Moleur F, Drouet C, Robert C, Guillermet C, Brambilla C, Brambilla E: In situ apoptotic cell labeling by TUNEL method: improvement and evaluation on cell preparations. J Histochem Cytochem 1996 (in press)
29. Going JJ: Efficiently estimated histologic cell counts. Hum Pathol 1995, 26:333-336
30. 2 protein in malignant and normal lymphoid cells. Cancer Res 1994, 54:256-260
31. 2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ 1994, 5:411-417
32. 2 protein. Am J Pathol 1994, 145:1036-1040
33. Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R: High prevalence of Bcl-2 oncoprotein expression in small cell lung cancer. Anticancer Res 1995, 15:503-505
34. 2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol 1995, 177:135-138
35. Al-Saffar N, Moore JV, Hasleton PS: A morphometric analysis of individual cell death in bronchial carcinoids. Cell Tissue Kinet 1990, 23:325-330
36. Marchetti A, Buttitta F, Merlo G, Diella F, Pellegrini S, Pepe S, Macchiarini P, Chella A, Angeletti CA, Callahan R, Bistocchi M, Squartini F: p53 alterations in non-small cell lung cancers correlate with metastatic involvement of hilar and mediastinal lymph nodes. Cancer Res 1993, 53:2846-2851
37. 2 oncoprotein in human neuroblastomas. Lab Invest 1995, 71:42-54
38. Brambilla E, Moro D, Gazzeri S, Brichon PY, Nagy-Mignotte H, Morel F, Jacrot M, Brambilla C Cytotoxic chemotherapy induces cell differentiation in small-cell lung carcinoma. J Clin Oncol 1991, 9:50-61
39. 2. Am J Pathol 1994, 145:1323-1336
40. Lohmann DR, Fesseler B, Pütz B, Reich U, Böhm J, Präuer H, Wünsch PH, Höfler H: Infrequent mutations of the p53 gene in pulmonary carcinoid tumors. Cancer Res 1993, 53:5797-5801
41. Chiou SK, Rao L, White E: Bcl-2 blocks p53-dependent apoptosis. Mol Cell Biol 1994, 14:2556-2563
42. Peled A, Zipori D, Rotter V: Cooperation between p53-dependent and p53-independent apoptotic pathways in myeloid cells. Cancer Res 1996, 56:2148-2156
43. 2 protein family analyzed with a yeast two-hybrid system. Proc Natl Acad Sci USA 1994, 91:9238-9242